Immunogenicity and Protective Efficacy of the DAR-901 Booster Vaccine in a Murine Model of Tuberculosis.

about

Next-Generation Vaccines Based on Bacille Calmette-Guérin.The current status, challenges, and future developments of new tuberculosis vaccines.

P2860

Q49829375-6DEF82E1-1B5C-45B0-9AC2-6A918E074804 Q52337140-46EC199C-2494-4F0E-B3B1-49DC95C6519B

P2860

Immunogenicity and Protective Efficacy of the DAR-901 Booster Vaccine in a Murine Model of Tuberculosis.

Item

http://www.wikidata.org/entity/Q36229621

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Immunogenicity and Protective ...... Murine Model of Tuberculosis.

@ast

Immunogenicity and Protective ...... Murine Model of Tuberculosis.

@en

type

Item

label

Immunogenicity and Protective ...... Murine Model of Tuberculosis.

@ast

Immunogenicity and Protective ...... Murine Model of Tuberculosis.

@en

prefLabel

Immunogenicity and Protective ...... Murine Model of Tuberculosis.

@ast

Immunogenicity and Protective ...... Murine Model of Tuberculosis.

@en

P1476

Immunogenicity and Protective ...... Murine Model of Tuberculosis.

@en

P2093

Alison Hogg

http://www.w3.org/2001/XMLSchema#string

Belinda Dagg

http://www.w3.org/2001/XMLSchema#string

C Fordham von Reyn

http://www.w3.org/2001/XMLSchema#string

Dominick Laddy

http://www.w3.org/2001/XMLSchema#string

Jacqueline Schaeffer

http://www.w3.org/2001/XMLSchema#string

James Keeble

http://www.w3.org/2001/XMLSchema#string

Krystal Hill

http://www.w3.org/2001/XMLSchema#string

Mei Mei Ho

http://www.w3.org/2001/XMLSchema#string

Robert D Arbeit

http://www.w3.org/2001/XMLSchema#string

Timothy Lahey

http://www.w3.org/2001/XMLSchema#string

P2860

A mutation in the interferon-gamma-receptor gene and susceptibility to mycobacterial infection

Interferon-gamma-receptor deficiency in an infant with fatal bacille Calmette-Guérin infection

A review of preclinical animal models utilised for TB vaccine evaluation in the context of recent human efficacy data

Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial

Progress in tuberculosis vaccine development and host-directed therapies--a state of the art review.

Polyantigenic interferon-γ responses are associated with protection from TB among HIV-infected adults with childhood BCG immunization.

Heterosubtypic protection against pathogenic human and avian influenza viruses via in vivo electroporation of synthetic consensus DNA antigens.

MVA.85A boosting of BCG and an attenuated, phoP deficient M. tuberculosis vaccine both show protective efficacy against tuberculosis in rhesus macaques.

Interferon γ responses to mycobacterial antigens protect against subsequent HIV-associated tuberculosis.

Immunogenicity of a protective whole cell mycobacterial vaccine in HIV-infected adults: a phase III study in Tanzania

P304

e0168521

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0168521

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-12-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27997597

http://www.w3.org/2001/XMLSchema#string

P921

Akafuba bulwadde

P932

5173179

http://www.w3.org/2001/XMLSchema#string

Immunogenicity and Protective Efficacy of the DAR-901 Booster Vaccine in a Murine Model of Tuberculosis.

about

P2860

P2860

Immunogenicity and Protective Efficacy of the DAR-901 Booster Vaccine in a Murine Model of Tuberculosis.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P921

P932